Dynavax: Buy On Weakness Ahead Of November's PDUFA Date

By: via Benzinga
Dynavax Technologies Corporation (NASDAQ: DVAX) is awaiting its tryst with the FDA after a failed attempt in August. Against this ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.